126 related articles for article (PubMed ID: 8938702)
1. Mild clinical phenotype in a 12-year-old boy with partial merosin deficiency and central and peripheral nervous system abnormalities.
Mora M; Moroni I; Uziel G; di Blasi C; Barresi R; Farina L; Morandi L
Neuromuscul Disord; 1996 Oct; 6(5):377-81. PubMed ID: 8938702
[TBL] [Abstract][Full Text] [Related]
2. Limb girdle muscular dystrophy due to LAMA2 mutations: diagnostic difficulties due to associated peripheral neuropathy.
Chan SH; Foley AR; Phadke R; Mathew AA; Pitt M; Sewry C; Muntoni F
Neuromuscul Disord; 2014 Aug; 24(8):677-83. PubMed ID: 24957499
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of syntrophin, dystroglycan, and merosin in a female infant with a congenital muscular dystrophy phenotype lacking cysteine-rich and C-terminal domains of dystrophin.
Tachi N; Ohya K; Chiba S; Matsuo M; Patria SY; Matsumura K
Neurology; 1997 Aug; 49(2):579-83. PubMed ID: 9270600
[TBL] [Abstract][Full Text] [Related]
4. Merosin positive congenital muscular dystrophy with mental deficiency, epilepsy and MRI changes in the cerebral white matter.
Echenne B; Rivier F; Jellali AJ; Azais M; Mornet D; Pons F
Neuromuscul Disord; 1997 May; 7(3):187-90. PubMed ID: 9185183
[TBL] [Abstract][Full Text] [Related]
5. Variable clinical phenotype in merosin-deficient congenital muscular dystrophy associated with differential immunolabelling of two fragments of the laminin alpha 2 chain.
Sewry CA; Naom I; D'Alessandro M; Sorokin L; Bruno S; Wilson LA; Dubowitz V; Muntoni F
Neuromuscul Disord; 1997 May; 7(3):169-75. PubMed ID: 9185180
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities of dystrophin, the sarcoglycans, and laminin alpha2 in the muscular dystrophies.
Jones KJ; Kim SS; North KN
J Med Genet; 1998 May; 35(5):379-86. PubMed ID: 9610800
[TBL] [Abstract][Full Text] [Related]
7. Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle.
Philpot J; Sewry C; Pennock J; Dubowitz V
Neuromuscul Disord; 1995 Jul; 5(4):301-5. PubMed ID: 7580243
[TBL] [Abstract][Full Text] [Related]
8. Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy.
Vachon PH; Xu H; Liu L; Loechel F; Hayashi Y; Arahata K; Reed JC; Wewer UM; Engvall E
J Clin Invest; 1997 Oct; 100(7):1870-81. PubMed ID: 9312189
[TBL] [Abstract][Full Text] [Related]
9. Preserved merosin M-chain (or laminin-alpha 2) expression in skeletal muscle distinguishes Walker-Warburg syndrome from Fukuyama muscular dystrophy and merosin-deficient congenital muscular dystrophy.
Voit T; Sewry CA; Meyer K; Hermann R; Straub V; Muntoni F; Kahn T; Unsöld R; Helliwell TR; Appleton R
Neuropediatrics; 1995 Jun; 26(3):148-55. PubMed ID: 7477753
[TBL] [Abstract][Full Text] [Related]
10. Normal expression of adhalin and merosin in ovine congenital progressive muscular dystrophy.
Johnsen RD; Laing NG; Huxtable CR; Kakulas BA
Aust Vet J; 1997 Mar; 75(3):215-6. PubMed ID: 9088516
[No Abstract] [Full Text] [Related]
11. Expression of laminin chains in skin in merosin-deficient congenital muscular dystrophy.
Sewry CA; D'Alessandro M; Wilson LA; Sorokin LM; Naom I; Bruno S; Ferlini A; Dubowitz V; Muntoni F
Neuropediatrics; 1997 Aug; 28(4):217-22. PubMed ID: 9309712
[TBL] [Abstract][Full Text] [Related]
12. Sequential study of central and peripheral nervous system involvement in an infant with merosin-deficient congenital muscular dystrophy.
Mercuri E; Pennock J; Goodwin F; Sewry C; Cowan F; Dubowitz L; Dubowitz V; Muntoni F
Neuromuscul Disord; 1996 Dec; 6(6):425-9. PubMed ID: 9027850
[TBL] [Abstract][Full Text] [Related]
13. Merosin-deficient congenital muscular dystrophy type 1A.
Buteică E; Roşulescu E; Burada F; Stănoiu B; Zăvăleanu M
Rom J Morphol Embryol; 2008; 49(2):229-33. PubMed ID: 18516331
[TBL] [Abstract][Full Text] [Related]
14. Expression of laminin subunits in congenital muscular dystrophy.
Sewry CA; Philpot J; Mahony D; Wilson LA; Muntoni F; Dubowitz V
Neuromuscul Disord; 1995 Jul; 5(4):307-16. PubMed ID: 7580244
[TBL] [Abstract][Full Text] [Related]
15. Demyelinating peripheral neuropathy in merosin-deficient congenital muscular dystrophy.
Shorer Z; Philpot J; Muntoni F; Sewry C; Dubowitz V
J Child Neurol; 1995 Nov; 10(6):472-5. PubMed ID: 8576559
[TBL] [Abstract][Full Text] [Related]
16. Laminin alpha 2 (merosin)-deficient muscular dystrophy and demyelinating neuropathy in two cats.
O'Brien DP; Johnson GC; Liu LA; Guo LT; Engvall E; Powell HC; Shelton GD
J Neurol Sci; 2001 Aug; 189(1-2):37-43. PubMed ID: 11535231
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-3 and sarcoglycans in the vacuolar myopathies and centronuclear myopathy.
Inose M; Higuchi I; Nakagawa M; Kashio N; Osame M
Muscle Nerve; 1999 Aug; 22(8):1080-6. PubMed ID: 10417791
[TBL] [Abstract][Full Text] [Related]
18. Laminin alpha 2-chain gene mutations in two siblings presenting with limb-girdle muscular dystrophy.
Naom I; D'Alessandro M; Sewry CA; Philpot J; Manzur AY; Dubowitz V; Muntoni F
Neuromuscul Disord; 1998 Oct; 8(7):495-501. PubMed ID: 9829280
[TBL] [Abstract][Full Text] [Related]
19. Congenital muscular dystrophy associated with merosin deficiency.
North KN; Specht LA; Sethi RK; Shapiro F; Beggs AH
J Child Neurol; 1996 Jul; 11(4):291-5. PubMed ID: 8807418
[TBL] [Abstract][Full Text] [Related]
20. Nonmuscular involvement in merosin-negative congenital muscular dystrophy.
Gilhuis HJ; ten Donkelaar HJ; Tanke RB; Vingerhoets DM; Zwarts MJ; Verrips A; Gabreëls FJ
Pediatr Neurol; 2002 Jan; 26(1):30-6. PubMed ID: 11814732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
